SANUWAVE HEALTH, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0186 USD | +0.54% |
|
-11.00% | +43.08% |
| 10/05 | Transcript : SANUWAVE Health, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
| 09/05 | SANUWAVE Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to SANUWAVE Second Quar...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The Company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and others. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing from within. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression (PACE) technology to converge at precise selected targets to produce an extremely short duration compression burst.
Calendar
14/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +43.08% | 21.2M | |
| -5.29% | 182B | |
| +1.04% | 114B | |
| -5.49% | 67.76B | |
| +4.06% | 51.91B | |
| +7.21% | 43.23B | |
| +6.07% | 41.07B | |
| +22.81% | 32.07B | |
| +15.86% | 25B | |
| -2.65% | 24.55B |
- Stock Market
- Equities
- SNWV Stock
- News SANUWAVE Health, Inc.
- Transcript : SANUWAVE Health, Inc., Q2 2022 Earnings Call, Aug 16, 2022
